SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-21-019946
Filing Date
2021-02-10
Accepted
2021-02-10 17:29:34
Documents
15
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A casi-20200930x10qa.htm   iXBRL 10-Q/A 71971
2 EXHIBIT 3.2 casi-20200930xex3d2.htm EX-3.2 70042
3 EXHIBIT 31.3 casi-20200930xex31d3.htm EX-31.3 3789
4 EXHIBIT 31.4 casi-20200930xex31d4.htm EX-31.4 3780
  Complete submission text file 0001104659-21-019946.txt   315760

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA casi-20200930.xsd EX-101.SCH 2772
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20200930_lab.xml EX-101.LAB 16145
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20200930_pre.xml EX-101.PRE 13601
8 EXTRACTED XBRL INSTANCE DOCUMENT casi-20200930x10qa_htm.xml XML 6391
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-20713 | Film No.: 21615253
SIC: 2836 Biological Products, (No Diagnostic Substances)